CHELMSFORD, Mass., Jan. 23 /PRNewswire-FirstCall/ -- Magellan Biosciences, a leading provider of point-of-care products, automated laboratory systems, and consumables for clinical diagnostics and biomedical research, announced that its subsidiaries, TekCel and Dynex Technologies, will feature a selection of their automated laboratory systems in booth #175 at LabAutomation2006 from January 22-24 at the Palm Springs Convention Center in California.
TekCel will demonstrate its innovative TubeServer(TM) module, the "brains" of its TubeStore(TM) /Server localized-storage system for secure compound management, which features integrated active thaw, application-program interface, handoff to third-party device, and integrated 1D and 2D barcode reading. The system delivers huge advantages in flexibility, speed, throughput, ease of use, and security of samples for drug discovery and other critical biomedical-research applications. Multiple users can simultaneously cherry pick, process, and store jobs for execution immediately or in the future, while the integrated input/output device enables users to deliver multiple racks in and out of storage at the same time. In addition, the system tracks every 2D-barcoded tube on entry to and exit from the system and samples remain in a temperature-controlled, inert environment -- right up to the moment they are delivered -- to ensure sample security and extended sample lifetimes.
Dynex will preview its new DS2(TM) system, a fully automated laboratory workstation designed for the needs of demanding lower-throughput clinical labs -- from immunology to infectious disease, food, and drugs-of-abuse testing. Based on the company's higher-throughput DSX(TM), the DS2 features advanced automation and precise liquid-handling capabilities. Reliable, cost- effective, and easy to use and maintain, the DS2 automated workstation can process two 96-well microplates and up to 12 different assays simultaneously, while the DSX can process up to 48 different assays on as many as four plates. The DS2 and DSX are each open systems that perform the entire complement of analytical steps required for virtually any ELISA immunoassay: adding samples and reagents, washing, incubating, and absorbance detecting. In addition, they feature the most advanced and user-friendly controls available, and operate as full walk-away systems with sample ID-bar-code reading, chain-of- custody, and instrument-diagnostic capabilities.
According to Magellan's President and CEO, Robert J. Rosenthal, both TekCel and Dynex take a platform-development approach to product design to share advances across product lines. "We start by listening very closely to customer demands. They know what will enable them to do their jobs easier and more effectively. In today's busy labs, people are concerned about sample integrity, security, and assay accuracy. They're looking for smart, walk-away systems that allow them to focus solely on the job at hand. And they don't want to have to design their processes around the limitations of their laboratory equipment. All of our systems offer the utmost flexibility, ease of use, and security -- allowing customers to worry about what's most important to them: their critical research, or making rapid and accurate diagnoses to improve health outcomes."
The leader in localized secure-storage solutions addressing a variety of researcher needs from storage through screening result, TekCel's modular, scalable storage products include sample-management and liquid-handling automation and associated software and proprietary consumables. Its systems yield dramatic improvements in efficiency and effectiveness, while providing unparalleled flexibility and security to ensure biological and chemical sample integrity and data fidelity. Founded in 1998, and headquartered in Hopkinton, Massachusetts, TekCel is a Magellan Biosciences company. For more information, visit http://www.tekcel.com.
About Dynex Technologies
The Experts in Microplate Analysis, Dynex Technologies, Inc. is a leading manufacturer of microplate instrumentation incorporating advanced detection and fully automated sample handling, consumables, and accessories used in clinical diagnostics, drug discovery, biomedical research, and industrial applications worldwide. Founded in 1952, and headquartered in Chantilly, Virginia, Dynex is a wholly owned subsidiary of Magellan Biosciences. For more information, visit http://www.dynextechnologies.com.
About Magellan Biosciences
Magellan Biosciences develops point-of-care products, related consumables, and automated laboratory systems for clinical diagnostics and biomedical research worldwide. These tools enable scientists and clinicians to produce better, more-reliable results. And improved results help drive better outcomes: a new understanding of health and disease, earlier, more-accurate diagnoses -- breakthrough discoveries that can lead to novel treatments, new cures -- innovations to enhance life. Magellan serves customers through its wholly owned subsidiaries: ESA Biosciences, Dynex Technologies, and TekCel. For more information, visit http://www.magellanbio.com.
Caroline A. Grossman